The Rational Vaccine is now available in Roatán, Honduras, and in Munich, Germany. See also the update on vaccine in the earlier post, below…
RVx is a therapeutic vaccine which aims to treat herpes simplex types 1 and 2. It is for people getting too many recurrences. Experience so far has shown that, after the first injection, you can expect to cease having nerve pains, and that you will have 50 percent fewer recurrences. After the course of three injections, some people cease having recurrences altogether and for the others, recurrences are very much less frequent. (Scientists would never risk saying “they stop altogether.”)
We attended a webinar about this vaccine .
See below, where the information we wrote about getting the vaccine at the GARM Clinic in Roatan is unchanged. We suggest you email Dr Luisa Veloz ([email protected]) directly. We hear that you will pay her US $150 for a first consultation (U.S. medical prices). Dr Veloz has been treating people with herpes simplex for years and is an expert.
What’s included in your evaluation? (copied from their page HSVconsult.com )
• Comprehensive review of your HSV history, outbreak frequency, and symptoms
• Assessment of neurological symptoms (back pain, tingling, insomnia, brain fog)
• Honest candidacy determination – including if you are not a fit
• Realistic outcome expectations based on 13+ years of clinical data
Getting the vaccine in Munich: the system has changed.
Since Dr Veloz is the most experienced physician with this investigational product, Dr Kroehle in Germany has asked her to do the initial consultation for people wishing to get the injections in Munich. Dr Veloz will then refer European patients directly to Dr Kroehle who will administer the injections. As described above, the consultation ($150) will be about eligibility and to answer all your questions. You will then pay €12,000 and receive the injections.
Summary: update on vaccine
To start the process vaccines for getting the injections in Munich, Germany, or in Roatán, Honduras, contact Dr. Luisa Veloz at [email protected] for the initial consultation.
Published 18/3/2026
